Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center.

ABSTRACT:

Background

High morbidity and mortality have been observed in patients with cancer and coronavirus disease 2019 (COVID-19); however, there are limited data on antimicrobial use, coinfections, and viral shedding.

Methods

We conducted a retrospective cohort study of adult patients at the Seattle Cancer Care Alliance diagnosed with COVID-19 between February 28, 2020 and June 15, 2020 to characterize antimicrobial use, coinfections, viral shedding, and outcomes within 30 days after diagnosis. Cycle threshold values were used as a proxy for viral load. We determined viral clearance, defined as 2 consecutive negative results using severe acute respiratory syndrome coronavirus 2 reverse-transcription polymerase chain reaction results through July 30, 2020.

Results

Seventy-on

SUBMITTER: Yoke LH 

PROVIDER: S-EPMC8083314 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature